Comments
Loading...

GoodRx Holdings Analyst Ratings

GDRXNASDAQ
Logo brought to you by Benzinga Data
$4.50
-0.02-0.44%
At close: -
$4.41
-0.09-1.97%
After Hours: 4:25 PM EDT
Consensus Rating1
Overweight
Highest Price Target1
$16.00
Lowest Price Target1
$4.50
Consensus Price Target1
$8.36

GoodRx Holdings Analyst Ratings and Price Targets | NASDAQ:GDRX | Benzinga

GoodRx Holdings Inc has a consensus price target of $8.36 based on the ratings of 28 analysts. The high is $16 issued by TD Cowen on May 16, 2024. The low is $4.5 issued by B of A Securities on January 2, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, Citigroup, and Keybanc on February 28, 2025, January 10, 2025, and January 8, 2025, respectively. With an average price target of $6.75 between Wells Fargo, Citigroup, and Keybanc, there's an implied 53.02% upside for GoodRx Holdings Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Nov 24
1
Dec 24
2
Jan
1
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Wells Fargo
Citigroup
Keybanc
Morgan Stanley
Barclays

1calculated from analyst ratings

Analyst Ratings for GoodRx Holdings

Buy NowGet Alert
02/28/2025Buy Now81.36%Wells Fargo
Stan Berenshteyn42%
$9 → $8MaintainsOverweightGet Alert
01/10/2025Buy Now41.68%Citigroup
Daniel Grosslight43%
$7 → $6.25MaintainsBuyGet Alert
01/08/2025Buy Now36.02%Keybanc
Scott Schoenhaus43%
$7 → $6MaintainsOverweightGet Alert
12/17/2024Buy Now36.02%Morgan Stanley
Craig Hettenbach59%
$7 → $6MaintainsEqual-WeightGet Alert
11/13/2024Buy Now58.69%Citigroup
Daniel Grosslight43%
$10 → $7MaintainsBuyGet Alert
11/11/2024Buy Now36.02%Barclays
Stephanie Davis40%
$10 → $6MaintainsOverweightGet Alert
08/16/2024Buy Now126.7%RBC Capital
Sean Dodge49%
$10 → $10ReiteratesOutperform → OutperformGet Alert
08/09/2024Buy Now92.69%UBS
Kevin Caliendo71%
$9 → $8.5MaintainsNeutralGet Alert
08/09/2024Buy Now126.7%Citigroup
Daniel Grosslight43%
$11 → $10MaintainsBuyGet Alert
06/10/2024Buy Now115.36%Morgan Stanley
Craig Hettenbach59%
$7 → $9.5MaintainsEqual-WeightGet Alert
05/23/2024Buy Now126.7%RBC Capital
Mark Mahaney81%
$8 → $10UpgradeSector Perform → OutperformGet Alert
05/20/2024Buy Now126.7%Barclays
Stephanie Davis40%
$9 → $10MaintainsOverweightGet Alert
05/16/2024Buy Now126.7%Raymond James
John Ransom75%
→ $10UpgradeMarket Perform → OutperformGet Alert
05/16/2024Buy Now262.71%TD Cowen
Charles Rhyee37%
$14 → $16MaintainsBuyGet Alert
04/10/2024Buy Now104.03%Keybanc
Scott Schoenhaus43%
→ $9UpgradeSector Weight → OverweightGet Alert
03/25/2024Buy Now126.7%Wells Fargo
Stan Berenshteyn42%
→ $10UpgradeEqual-Weight → OverweightGet Alert
03/08/2024Buy Now81.36%RBC Capital
Sean Dodge49%
$8 → $8ReiteratesSector Perform → Sector PerformGet Alert
03/01/2024Buy Now81.36%UBS
Kevin Caliendo71%
$5 → $8MaintainsNeutralGet Alert
03/01/2024Buy Now70.02%Wells Fargo
Stan Berenshteyn42%
$6 → $7.5MaintainsEqual-WeightGet Alert
03/01/2024Buy Now81.36%RBC Capital
Sean Dodge49%
$7 → $8MaintainsSector PerformGet Alert
03/01/2024Buy Now70.02%Goldman Sachs
Eric Sheridan79%
$6.5 → $7.5MaintainsNeutralGet Alert
03/01/2024Buy Now81.36%Truist Securities
Jailendra Singh38%
$7.5 → $8MaintainsHoldGet Alert
03/01/2024Buy Now217.37%TD Cowen
Charles Rhyee37%
$12 → $14MaintainsOutperformGet Alert
03/01/2024Buy Now126.7%JP Morgan
Lisa Gill59%
$7 → $10UpgradeNeutral → OverweightGet Alert
03/01/2024Buy Now104.03%Barclays
Steve Valiquette53%
$8 → $9MaintainsOverweightGet Alert
02/26/2024Buy Now81.36%Leerink Partners
Michael Cherny79%
→ $8Initiates → OutperformGet Alert
01/16/2024Buy Now58.69%RBC Capital
Sean Dodge49%
$5 → $7MaintainsSector PerformGet Alert
01/12/2024Buy Now70.02%Truist Securities
Jailendra Singh38%
$5.5 → $7.5MaintainsHoldGet Alert
01/02/2024Buy Now2.01%B of A Securities
Michael Cherny79%
$8 → $4.5DowngradeBuy → UnderperformGet Alert
11/17/2023Buy Now36.02%JP Morgan
Doug Anmuth85%
$7 → $6MaintainsNeutralGet Alert
11/13/2023Buy Now36.02%Goldman Sachs
Eric Sheridan79%
$7 → $6MaintainsNeutralGet Alert
11/10/2023Buy Now13.35%RBC Capital
Sean Dodge49%
$8 → $5MaintainsSector PerformGet Alert
11/10/2023Buy Now36.02%Goldman Sachs
Eric Sheridan79%
$7 → $6MaintainsNeutralGet Alert
11/10/2023Buy Now24.68%Truist Securities
Jailendra Singh38%
$8 → $5.5MaintainsHoldGet Alert
11/10/2023Buy Now24.68%Morgan Stanley
Ricky Goldwasser78%
$8 → $5.5MaintainsEqual-WeightGet Alert
09/14/2023Buy Now58.69%JP Morgan
Doug Anmuth85%
$6 → $7MaintainsNeutralGet Alert
08/11/2023Buy Now58.69%Goldman Sachs
Eric Sheridan79%
$6.25 → $7MaintainsNeutralGet Alert
08/10/2023Buy Now81.36%Deutsche Bank
George Hill62%
$6 → $8MaintainsHoldGet Alert
08/10/2023Buy Now126.7%Guggenheim
Sandy Draper72%
$8 → $10MaintainsBuyGet Alert
08/10/2023Buy Now36.02%JP Morgan
Doug Anmuth85%
$5 → $6MaintainsNeutralGet Alert
08/10/2023Buy Now149.37%Citigroup
Daniel Grosslight43%
$7 → $11MaintainsBuyGet Alert
08/10/2023Buy Now126.7%Evercore ISI Group
Mark Mahaney81%
$7 → $10MaintainsIn-LineGet Alert
08/10/2023Buy Now58.69%Goldman Sachs
Eric Sheridan79%
$6.25 → $7MaintainsNeutralGet Alert
08/10/2023Buy Now81.36%Credit Suisse
Jonathan Yong64%
$7 → $8MaintainsNeutralGet Alert
08/10/2023Buy Now81.36%RBC Capital
Sean Dodge49%
$6 → $8MaintainsSector PerformGet Alert
08/10/2023Buy Now115.36%DA Davidson
Robert Simmons54%
→ $9.5UpgradeNeutral → BuyGet Alert
08/10/2023Buy Now58.69%Wells Fargo
Stan Berenshteyn42%
$6 → $7MaintainsEqual-WeightGet Alert
07/31/2023Buy Now172.03%TD Cowen
Charles Rhyee37%
$6.5 → $12UpgradeMarket Perform → OutperformGet Alert
07/18/2023Buy Now58.69%Truist Securities
Jailendra Singh38%
$6 → $7MaintainsHoldGet Alert
07/17/2023Buy Now81.36%Morgan Stanley
Ricky Goldwasser78%
$6 → $8MaintainsEqual-WeightGet Alert
07/12/2023Buy NowKeybanc
Scott Schoenhaus43%
MaintainsSector WeightGet Alert
05/11/2023Buy Now81.36%B of A Securities
Michael Cherny79%
$9 → $8MaintainsBuyGet Alert
05/11/2023Buy Now36.02%RBC Capital
Sean Dodge49%
→ $6ReiteratesSector Perform → Sector PerformGet Alert
05/11/2023Buy Now41.68%Goldman Sachs
Eric Sheridan79%
$7 → $6.25MaintainsNeutralGet Alert
05/11/2023Buy Now58.69%Citigroup
Daniel Grosslight43%
$7.5 → $7MaintainsBuyGet Alert
03/08/2023Buy Now70.02%Citigroup
Daniel Grosslight43%
$7 → $7.5MaintainsBuyGet Alert
03/07/2023Buy Now81.36%Deutsche Bank
George Hill62%
$7 → $8MaintainsHoldGet Alert
03/02/2023Buy Now58.69%Goldman Sachs
Eric Sheridan79%
$8 → $7MaintainsNeutralGet Alert
03/02/2023Buy Now81.36%Credit Suisse
Jonathan Yong64%
$9 → $8MaintainsNeutralGet Alert
03/02/2023Buy Now36.02%Wells Fargo
Stan Berenshteyn42%
$5.5 → $6MaintainsEqual-WeightGet Alert
03/01/2023Buy Now58.69%Goldman Sachs
Eric Sheridan79%
$8 → $7MaintainsNeutralGet Alert
01/18/2023Buy Now81.36%Barclays
Steve Valiquette53%
$9 → $8MaintainsOverweightGet Alert
12/01/2022Buy Now58.69%Citigroup
Daniel Grosslight43%
→ $7Initiates → BuyGet Alert
11/09/2022Buy Now81.36%Goldman Sachs
Eric Sheridan79%
$10 → $8MaintainsNeutralGet Alert
11/09/2022Buy Now36.02%RBC Capital
Sean Dodge49%
$11 → $6MaintainsSector PerformGet Alert
11/09/2022Buy Now36.02%Morgan Stanley
Ricky Goldwasser78%
$10 → $6MaintainsEqual-WeightGet Alert
11/04/2022Buy Now81.36%JP Morgan
Doug Anmuth85%
$10 → $8UpgradeUnderweight → NeutralGet Alert
10/11/2022Buy Now104.03%Barclays
Ross Sandler69%
$13 → $9MaintainsOverweightGet Alert
09/16/2022Buy NowKeybanc
Scott Schoenhaus43%
Initiates → Sector WeightGet Alert
09/07/2022Buy Now47.35%Truist Securities
Jailendra Singh38%
→ $6.5Initiates → HoldGet Alert
08/12/2022Buy Now81.36%DA Davidson
Robert Simmons54%
→ $8Initiates → NeutralGet Alert
08/10/2022Buy Now126.7%Morgan Stanley
Ricky Goldwasser78%
$10.5 → $10MaintainsEqual-WeightGet Alert
08/09/2022Buy Now149.37%Credit Suisse
Jonathan Yong64%
$10 → $11MaintainsNeutralGet Alert
08/09/2022Buy Now126.7%Goldman Sachs
Eric Sheridan79%
$9 → $10MaintainsNeutralGet Alert
08/09/2022Buy Now149.37%RBC Capital
Sean Dodge49%
$6.5 → $11MaintainsSector PerformGet Alert
08/09/2022Buy Now194.7%Barclays
Steve Valiquette53%
$12 → $13MaintainsOverweightGet Alert
08/09/2022Buy Now149.37%SVB Leerink
Stephanie Davis40%
$8 → $11MaintainsMarket PerformGet Alert
07/20/2022Buy Now172.03%Barclays
Steve Valiquette53%
$15 → $12MaintainsOverweightGet Alert
07/18/2022Buy Now194.7%Guggenheim
Sandy Draper72%
$17 → $13MaintainsBuyGet Alert
06/23/2022Buy Now47.35%RBC Capital
Sean Dodge49%
$8 → $6.5MaintainsSector PerformGet Alert
06/22/2022Buy Now36.02%Baird
Vikram Kesavabhotla50%
$7 → $6MaintainsNeutralGet Alert
06/13/2022Buy Now104.03%Cowen & Co.
Charles Rhyee37%
$22 → $9MaintainsMarket PerformGet Alert
06/10/2022Buy Now104.03%Goldman Sachs
Eric Sheridan79%
$12 → $9DowngradeBuy → NeutralGet Alert
06/06/2022Buy Now149.37%B of A Securities
Michael Cherny79%
→ $11Reinstates → BuyGet Alert
06/01/2022Buy Now58.69%Baird
Vikram Kesavabhotla50%
$10 → $7DowngradeOutperform → NeutralGet Alert
05/20/2022Buy Now138.03%Morgan Stanley
Ricky Goldwasser78%
$19 → $10.5MaintainsEqual-WeightGet Alert
05/12/2022Buy Now104.03%Wells Fargo
Stan Berenshteyn42%
$20 → $9MaintainsEqual-WeightGet Alert
05/11/2022Buy Now172.03%Goldman Sachs
Eric Sheridan79%
$30 → $12MaintainsBuyGet Alert
05/11/2022Buy Now126.7%Deutsche Bank
George Hill62%
$20 → $10MaintainsHoldGet Alert
05/11/2022Buy Now126.7%Credit Suisse
Jonathan Yong64%
$22 → $10MaintainsNeutralGet Alert
05/10/2022Buy NowSVB Leerink
Stephanie Davis Demko45%
DowngradeOutperform → Market PerformGet Alert
05/10/2022Buy Now240.04%Barclays
Steve Valiquette53%
$28 → $15MaintainsOverweightGet Alert
05/10/2022Buy Now172.03%Evercore ISI Group
Mark Mahaney81%
$28 → $12DowngradeOutperform → In-LineGet Alert
05/10/2022Buy NowRaymond James
John Ransom75%
DowngradeOutperform → Market PerformGet Alert
05/10/2022Buy Now81.36%RBC Capital
Sean Dodge49%
$35 → $8DowngradeOutperform → Sector PerformGet Alert
04/11/2022Buy Now353.39%Wells Fargo
Stan Berenshteyn42%
→ $20Initiates → Equal-WeightGet Alert
04/07/2022Buy Now444.07%Guggenheim
Sandy Draper72%
→ $24Initiates → BuyGet Alert

FAQ

Q

What is the target price for GoodRx Holdings (GDRX) stock?

A

The latest price target for GoodRx Holdings (NASDAQ:GDRX) was reported by Wells Fargo on February 28, 2025. The analyst firm set a price target for $8.00 expecting GDRX to rise to within 12 months (a possible 81.36% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for GoodRx Holdings (GDRX)?

A

The latest analyst rating for GoodRx Holdings (NASDAQ:GDRX) was provided by Wells Fargo, and GoodRx Holdings maintained their overweight rating.

Q

When was the last upgrade for GoodRx Holdings (GDRX)?

A

The last upgrade for GoodRx Holdings Inc happened on May 23, 2024 when RBC Capital raised their price target to $10. RBC Capital previously had a sector perform for GoodRx Holdings Inc.

Q

When was the last downgrade for GoodRx Holdings (GDRX)?

A

The last downgrade for GoodRx Holdings Inc happened on January 2, 2024 when B of A Securities changed their price target from $8 to $4.5 for GoodRx Holdings Inc.

Q

When is the next analyst rating going to be posted or updated for GoodRx Holdings (GDRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GoodRx Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GoodRx Holdings was filed on February 28, 2025 so you should expect the next rating to be made available sometime around February 28, 2026.

Q

Is the Analyst Rating GoodRx Holdings (GDRX) correct?

A

While ratings are subjective and will change, the latest GoodRx Holdings (GDRX) rating was a maintained with a price target of $9.00 to $8.00. The current price GoodRx Holdings (GDRX) is trading at is $4.41, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch